U.S. COVID-19 vaccine safety surveillance results for the over 65s Vaccine Coronavirus Disease COVID Over65s medrxivpreprint US_FDA Acumen CMSGov Stanford
By Neha MathurNov 7 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers conducted near real-time safety monitoring in the United States elderly population for 14 safety outcomes weekly following the coronavirus disease 2019 vaccination. In particular, the researchers focused on safety signals following vaccination with Pfizer BioNTech , Moderna , and Janssen COVID-19 vaccines.
The US Food and Drug Administration and CMS have routinely used a safety surveillance method for influenza vaccines in the past decade. For COVID-19 surveillance, this method deployed sequential hypothesis testing prospectively as the vaccine data accumulated to detect potential safety signals during the earlier phase of surveillance. It also proved sensitive enough to quickly screen vaccine safety signals for further evaluation in robust epidemiologic studies.
The researchers compared the observed number of each outcome in the COVID-19 vaccinated population to an expected number based on the historical outcome rate in a similar COVID-19 unvaccinated population before the pandemic, adjusted for the delay in claims processing and standardized by nursing home residency status, age, gender, and ethnicity.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Viral whole genome study in the United States identifies ORF-disrupting mutations in monkeypox virusResearchers used whole genome sequencing to evaluate monkeypox virus samples from Washington and Ohio states in the United States and identified 25 samples with open reading frame (ORF)-disrupting mutations.
Read more »
Multinational consensus to end COVID-19 pandemicMultinational consensus to end COVID-19 pandemic NaturePortfolio UniBarcelona Pandemic COVID19 SARSCoV2
Read more »
Evaluating dual direct-acting antivirals against persistent COVID-19Researchers assessed the efficiency of dual direct-acting antivirals in treating persistent coronavirus disease 2019 (COVID-19).
Read more »
Dad calls for more COVID memorials as son dies after contracting the virus'We don't want Cameron to be forgotten'
Read more »
COVID-19 amplifies damage to the central nervous system in Alzheimer's diseaseCOVID-19 amplifies damage to the central nervous system in Alzheimer's disease Alzheimers Disease CentralNervousSystem CNS Coronavirus COVID Encephalitis Endothelialitis SpikeProtein Microvasculature ElsevierNews GnomeDx OhioState RutgersU
Read more »